Search results
Multiple omics levels of chronic lymphocytic leukemia - Cell Death Discovery
Nature· 2 days agoChronic lymphocytic leukemia (CLL) is a lymphoproliferative malignancy characterized by the proliferation of functionally mature but ...
Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL
MedPage Today· 6 days agoA fixed-duration, three-drug regimen for chronic lymphocytic leukemia (CLL) achieved deep and...
EHA 2024: Brukinsa/Venclexta for CLL/SLL lacks control arm in SEQUOIA trial
Clinical Trials Arena via Yahoo Finance· 6 days agoThis trial evaluated the efficacy of AbbVie/Roche's Venclexta (venetoclax) and BeiGene's Brukinsa...
Biotech With 345% Run Posts A 'Clear Win' In Cancer Treatment
Investor's Business Daily· 6 days agoThe company tested its treatment, dubbed NX-5948, in patients with relapsed or refractory forms of ...
LADENBURG THALM/SH SH Downgrades Coeptis Therapeutics (NASDAQ:COEP) to Hold
ETF DAILY NEWS· 1 day agoCoeptis Therapeutics (NASDAQ:COEP – Get Free Report) was downgraded by equities research analysts at LADENBURG THALM/SH SH from a “strong-buy” rating to a “hold” rating in a research note issued ...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 2 days agoLilly gained approvals for some other new drugs in 2023. These included Omvoh for ulcerative colitis...
Why Is Penny Stock Mustang Bio Trading Over 190% On Monday? - Mustang Bio (NASDAQ:MBIO)
Benzinga· 6 days agoMB-106 is being developed in a collaboration between Mustang and Fred Hutch Cancer Center to treat...
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket...
Benzinga· 6 days agoShares of Nurix Therapeutics, Inc. NRIX rose sharply in today's pre-market trading after the company announced results from its ongoing clinical trial of NX-5948 in patients with relapsed refractory ...
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the...
NewMediaWire via Yahoo Finance· 5 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen,...
EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer
MedPage Today· 2 days agoFollowing the FDA's lead, the European Medicines Agency will require labeling for CAR T-cell...